{"id":"https://openalex.org/W3028098515","doi":"https://doi.org/10.1080/13506129.2020.1758658","title":"Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank","display_name":"Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank","publication_year":2020,"publication_date":"2020-05-19","ids":{"openalex":"https://openalex.org/W3028098515","doi":"https://doi.org/10.1080/13506129.2020.1758658","mag":"3028098515","pmid":"https://pubmed.ncbi.nlm.nih.gov/32425064"},"language":"en","primary_location":{"id":"doi:10.1080/13506129.2020.1758658","doi":"https://doi.org/10.1080/13506129.2020.1758658","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13506129.2020.1758658","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13506129.2020.1758658?needAccess=true","source":{"id":"https://openalex.org/S25535963","display_name":"Amyloid","issn_l":"1350-6129","issn":["1350-6129","1744-2818"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/13506129.2020.1758658?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075425205","display_name":"Margaret M. Parker","orcid":"https://orcid.org/0000-0001-6368-5033","observed_orcids":["https://orcid.org/0000-0001-6368-5033"]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret M. Parker","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065250118","display_name":"Simina Ticau","orcid":"https://orcid.org/0000-0003-1096-9627","observed_orcids":["https://orcid.org/0000-0003-1096-9627"]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simina Ticau","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102937207","display_name":"James Thomas Butler","orcid":"https://orcid.org/0000-0003-1978-6894","observed_orcids":["https://orcid.org/0000-0003-1978-6894"]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Butler","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110063622","display_name":"David V. Erbe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Erbe","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005623896","display_name":"Madeline P. Merkel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madeline Merkel","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037352811","display_name":"Emre Aldinc","orcid":"https://orcid.org/0000-0002-7237-4760","observed_orcids":["https://orcid.org/0000-0002-7237-4760"]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emre Aldinc","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049199193","display_name":"Gregory Hinkle","orcid":"https://orcid.org/0000-0002-5414-5219","observed_orcids":["https://orcid.org/0000-0002-5414-5219"]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Hinkle","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004125788","display_name":"Paul Nioi","orcid":"https://orcid.org/0000-0002-4804-8148","observed_orcids":["https://orcid.org/0000-0002-4804-8148"]},"institutions":[{"id":"https://openalex.org/I145311141","display_name":"Alnylam Pharmaceuticals (United States)","ror":"https://ror.org/00thr3w71","country_code":"US","type":"company","lineage":["https://openalex.org/I145311141"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul Nioi","raw_affiliation_strings":["Alnylam Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alnylam Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I145311141"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5004125788"],"corresponding_institution_ids":["https://openalex.org/I145311141"],"apc_list":null,"apc_paid":null,"fwci":0.5015,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.71985158,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"27","issue":"3","first_page":"184","last_page":"190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11335","display_name":"Prion Diseases and Protein Misfolding","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prealbumin","display_name":"prealbumin","score":0.972000002861023},{"id":"https://openalex.org/keywords/ttr-tetramer-stabilization","display_name":"TTR tetramer stabilization","score":0.800000011920929},{"id":"https://openalex.org/keywords/vascular-disease","display_name":"vascular disease","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cerebrovascular-disease","display_name":"cerebrovascular disease","score":0.8889999985694885},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.9869999885559082},{"id":"https://openalex.org/keywords/genetic-association","display_name":"genetic association","score":0.5170000195503235},{"id":"https://openalex.org/keywords/uk-biobank","display_name":"UK Biobank","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7310741543769836},{"id":"https://openalex.org/C116567970","wikidata":"https://www.wikidata.org/wiki/Q864217","display_name":"Biobank","level":2,"score":0.7023231387138367},{"id":"https://openalex.org/C121157162","wikidata":"https://www.wikidata.org/wiki/Q419999","display_name":"Transthyretin","level":2,"score":0.6937098503112793},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6489722728729248},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6379820108413696},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.6134769916534424},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5825457572937012},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5273032188415527},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5229285955429077},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.45416173338890076},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4494308829307556},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.17734843492507935},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.16225409507751465},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10435342788696289},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002561","descriptor_name":"Cerebrovascular Disorders","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002561","descriptor_name":"Cerebrovascular Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002561","descriptor_name":"Cerebrovascular Disorders","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003643","descriptor_name":"Death","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003718","descriptor_name":"Denmark","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006579","descriptor_name":"Heterozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011228","descriptor_name":"Prealbumin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018070","descriptor_name":"Biological Specimen Banks","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D028227","descriptor_name":"Amyloid Neuropathies, Familial","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D056726","descriptor_name":"Genetic Association Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1080/13506129.2020.1758658","doi":"https://doi.org/10.1080/13506129.2020.1758658","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13506129.2020.1758658","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13506129.2020.1758658?needAccess=true","source":{"id":"https://openalex.org/S25535963","display_name":"Amyloid","issn_l":"1350-6129","issn":["1350-6129","1744-2818"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid","raw_type":"journal-article"},{"id":"doi:10.1101/771626","doi":"https://doi.org/10.1101/771626","is_oa":true,"landing_page_url":"https://doi.org/10.1101/771626","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2019/09/21/771626.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmid:32425064","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32425064","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/13506129.2020.1758658","doi":"https://doi.org/10.1080/13506129.2020.1758658","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13506129.2020.1758658","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13506129.2020.1758658?needAccess=true","source":{"id":"https://openalex.org/S25535963","display_name":"Amyloid","issn_l":"1350-6129","issn":["1350-6129","1744-2818"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G5331993534","display_name":"UK Biobank (core renewal)","funder_award_id":"MC_PC_17228","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320309056","display_name":"Alnylam Pharmaceuticals","ror":"https://ror.org/00thr3w71"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3028098515.pdf","grobid_xml":"https://content.openalex.org/works/W3028098515.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W26155739","https://openalex.org/W163987580","https://openalex.org/W1483242733","https://openalex.org/W1539382679","https://openalex.org/W1585658616","https://openalex.org/W1972373816","https://openalex.org/W1972417329","https://openalex.org/W1974280458","https://openalex.org/W1986782676","https://openalex.org/W1996927016","https://openalex.org/W2022129666","https://openalex.org/W2038935930","https://openalex.org/W2053660767","https://openalex.org/W2067823521","https://openalex.org/W2083937742","https://openalex.org/W2084685424","https://openalex.org/W2084695544","https://openalex.org/W2092180837","https://openalex.org/W2094587801","https://openalex.org/W2095238968","https://openalex.org/W2115862827","https://openalex.org/W2128160816","https://openalex.org/W2131999691","https://openalex.org/W2138666552","https://openalex.org/W2158907165","https://openalex.org/W2188931003","https://openalex.org/W2212415077","https://openalex.org/W2415473920","https://openalex.org/W2501376604","https://openalex.org/W2551198464","https://openalex.org/W2597898852","https://openalex.org/W2734654754","https://openalex.org/W2737435306","https://openalex.org/W2739898475","https://openalex.org/W2755481227","https://openalex.org/W2795771604","https://openalex.org/W2888036721","https://openalex.org/W2895486342","https://openalex.org/W2901303766","https://openalex.org/W3038873882","https://openalex.org/W4247327446","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2128160816","https://openalex.org/W2232798794","https://openalex.org/W4404993797","https://openalex.org/W2761938090","https://openalex.org/W2089089577","https://openalex.org/W3136783297","https://openalex.org/W2795771604","https://openalex.org/W4403813177","https://openalex.org/W1976251569","https://openalex.org/W2049336811"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Destabilized":[2],"transthyretin":[3],"(TTR)":[4],"can":[5],"result":[6],"in":[7,44,58,68,196,212],"the":[8,21,59,69,102,185],"progressive,":[9],"fatal":[10],"disease":[11,43,126,133,138,163,193],"transthyretin-mediated":[12],"(ATTR)":[13],"amyloidosis.":[14],"A":[15],"stabilizing":[16],"TTR":[17,63,186,204],"mutation,":[18],"T119M,":[19],"is":[20,209],"basis":[22],"for":[23],"a":[24,45,72,197],"therapeutic":[25],"strategy":[26],"to":[27,50,117],"reduce":[28],"destabilized":[29],"TTR.":[30],"Recently,":[31],"T119M":[32,64,81,100,115,123,168,187,208],"was":[33,95,110,181],"associated":[34],"with":[35],"extended":[36],"lifespan":[37],"and":[38,83,93,124,161,170,175,189],"lower":[39],"risk":[40,190],"of":[41,76,86,99,191],"cerebrovascular":[42,91,137],"Danish":[46],"cohort.":[47],"We":[48],"aimed":[49],"determine":[51],"whether":[52],"this":[53,213],"finding":[54],"could":[55],"be":[56],"replicated":[57],"UK":[60,70,104],"Biobank.":[61],"Methods":[62],"carriers":[65,116,169],"were":[66,165],"identified":[67],"Biobank,":[71],"large":[73,198],"prospective":[74,199],"cohort":[75,200],"\u223c500,000":[77],"individuals.":[78],"Association":[79],"between":[80,122,167,184],"genotype":[82,188],"inpatient":[84],"diagnosis":[85,164],"vascular":[87,125,162,192],"disease,":[88,90,92],"cardiovascular":[89,132],"mortality":[94],"analyzed.":[96],"Results":[97],"Frequency":[98],"within":[101],"white":[103],"Biobank":[105],"population":[106],"(":[107,172],"n":[108],"=337,148)":[109],"0.4%.":[111],"Logistic":[112],"regression":[113,150],"comparing":[114],"non-carriers":[118,171],"found":[119],"no":[120,182],"association":[121,183],"(odds":[127],"ratio":[128],"[OR]=1.08;":[129],"p=":[130,135,140,145,173,176],".27),":[131],"(OR=1.08;":[134],".31),":[136],"(OR=1.1;":[139],".42),":[141],"or":[142,194],"death":[143,160,195],"(OR=1.2;":[144],".06).":[146],"Cox":[147],"proportional":[148],"hazards":[149],"showed":[151],"similar":[152,166],"results":[153],"(hazard":[154],"ratio>1,":[155],"p":[156],">.05).":[157],"Age":[158],"at":[159],".12":[174],".38,":[177],"respectively).":[178],"Conclusions":[179],"There":[180],"study,":[201],"indicating":[202],"that":[203],"tetramer":[205],"stabilization":[206],"through":[207],"not":[210],"protective":[211],"setting.":[214]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2020-05-29T00:00:00"}